Dieser Abschnitt ist nur in englischer Sprache verfügbar.

7. Share ownership information

7.1 Shareholdings of members of the Board of Directors

7.1 Shareholdings of members of the Board of Directors

The tables in this section are audited by the external auditor.

The following table shows the equity of the individual members of the Board of Directors and persons closely linked to them.

 

 

31.03.2023

 

31.03.2022

 

 

Total Shares

 

of which Restricted Shares 1)

 

RSUs

 

Options

 

Total Shares

 

of which Restricted Shares 2)

 

RSUs

 

Options

Robert F. Spoerry, Chair

 

58,214

 

10,812

 

 

 

 

 

56,629

 

12,261

 

 

 

 

Stacy Enxing Seng, Vice-Chair

 

9,748

 

3,652

 

 

 

 

 

9,063

 

4,319

 

 

 

 

Gregory (Greg) Behar, Member

 

1,164

 

1,164

 

 

 

 

 

479

 

479

 

 

 

 

Lynn Dorsey Bleil, Member

 

6,547

 

3,652

 

 

 

 

 

5,862

 

4,319

 

 

 

 

Lukas Braunschweiler, Member

 

17,842

 

3,652

 

 

 

65,228

 

29,457

 

2,967

 

700

 

96,016

Roland Diggelmann, Member

 

1,164

 

1,164

 

 

 

 

 

479

 

479

 

 

 

 

Julie Tay, Member 3)

 

685

 

685

 

 

 

 

 

 

 

 

 

 

 

 

Ronald van der Vis, Member

 

6,517

 

3,652

 

 

 

 

 

5,832

 

4,319

 

 

 

 

Jinlong Wang, Member

 

11,163

 

3,652

 

 

 

 

 

10,478

 

4,319

 

 

 

 

Adrian Widmer, Member

 

1,895

 

1,895

 

 

 

 

 

1,210

 

1,210

 

 

 

 

Total

 

114,939

 

33,980

 

 

 

65,228

 

119,489

 

34,672

 

700

 

96,016

1) These shares are subject to a restriction period which varies from June 1, 2023 to June 1, 2028 depending on the grant date.

2) These shares are subject to a restriction period which varies from June 1, 2022 to June 1, 2027 depending on the grant date.

3) New member of the Board of Directors since June 2022.

  For further details see also Note 7.4 in the consolidated financial statements.

The shareholding requirements set by the share ownership guidelines are entirely met by all members of the Board of Directors.

7.2 Shareholdings of members of the Management Board

7.2 Shareholdings of members of the Management Board

The tables in this section are audited by the external auditor.

The following tables show the equity of individual members of the Management Board and persons closely linked to them.

 

 

31.03.2023

 

31.03.2022

 

 

Shares 1)

 

PSUs

 

RSUs

 

Options

 

Shares 1)

 

PSUs

 

RSUs

 

Options

Arnd Kaldowski

 

19,191

 

10,527

 

 

 

211,720

 

14,597

 

9,627

 

 

 

189,888

Birgit Conix

 

195

 

2,388

 

 

 

10,378

 

195

 

991

 

 

 

4,655

Ludger Althoff

 

1,447

 

3,058

 

264

 

21,771

 

1,183

 

2,241

 

528

 

18,421

Claudio Bartesaghi

 

2,047

 

1,926

 

 

 

12,435

 

911

 

2,494

 

 

 

23,227 2)

Vicky Carr-Brendel

 

628

 

3,068

 

237

 

21,138 3)

 

474

 

2,206

 

474

 

17,603 3)

Christophe Fond

 

 

 

3,855

 

162

 

40,779

 

776

 

3,855

 

323

 

40,187

Martin Grieder

 

1,370

 

3,521

 

158

 

50,989

 

1,506

 

3,567

 

316

 

47,160

Robert (Rob) Woolley 4)

 

 

 

842

 

1,350

 

9,730

 

 

 

 

 

 

 

 

Total (active members)

 

24,878

 

29,185

 

2,171

 

378,940

 

19,642

 

24,981

 

1,641

 

341,141

Claude Diversi 5)

 

 

 

 

 

 

 

 

 

655

 

2,977

 

817

 

21,724

Andi Vonlanthen 5)

 

 

 

 

 

 

 

 

 

21,292

 

3,462

 

316

 

54,558

Total (including former members)

 

24,878

 

29,185

 

2,171

 

378,940

 

41,589

 

31,420

 

2,774

 

417,423

1) Shares are dividend entitled with full voting rights.

2) includes SARs (SARs grant the right to participate in the appreciation of Sonova shares without issuance of shares).

3) SARs were granted instead of options (SARs grant the right to participate in the appreciation of Sonova shares without issuance of shares).

4) Member of the Management Board since April 2022.

5) Member of the Management Board until March 2022.

  For further details see also Note 7.4 in the consolidated financial statements.

As of March 31, 2023 the shareholding requirements set by the share ownership guideline are met by all members of the Management Board except for one member, who re-committed to meet the requirements by June 30, 2023.

The following table shows the shareholding requirements relative to the fixed base salary and the indicative actual shareholdings.

 

 

 

 

 

Base salary

 

Share requirements 1)

 

Actual shares 2)

 

Fulfillment of share ownership guidelines

 

Share ownership ratio to base salary

 

 

in CHF

 

in CHF

 

in CHF

 

in %

 

ratio

Arnd Kaldowski, CEO

 

900,000

 

1,000,000

 

5,154,703

 

515

 

5.7

Other members of the MB 3)

 

412,957

 

200,000

 

295,030

 

148

 

0.7

1) Share requirements to be achieved for the CEO as of December 31, 2017 and for all other members of the MB after 41 months.

2) Calculated with Sonova closing share price of March 31, 2023.

3) Average of other members of the MB with shareholding requirements (excluding members of the MB that are still in build-up phase for shareholding requirements).

  The calculation of fulfillment and the ratio to base salary of the share ownership shown above are included for illustration purposes only.

The following table shows a detailed breakdown of the outstanding options of the members of the Management Board.

31.03.2023

 

 

Options EEAP 23 1)

 

Options EEAP 22 2)

 

Options EEAP 21 3)

 

Options EEAP 20 4)

 

Options EEAP 19 5)

 

Options EEAP 18 6)

 

Options EEAP 17 7)

 

Total options

Arnd Kaldowski

 

21,832

 

16,871

 

25,454

 

28,119

 

32,901

 

86,543 8)

 

 

 

211,720

Birgit Conix

 

5,723

 

4,655

 

 

 

 

 

 

 

 

 

 

 

10,378

Ludger Althoff

 

3,350

 

2,734

 

4,736

 

5,668

 

5,283

 

 

 

 

 

21,771

Claudio Bartesaghi

 

 

 

2,355

 

4,210

 

4,649

 

1,221

 

 

 

 

 

12,435

Vicky Carr-Brendel

 

3,535 9)

 

2,769 9)

 

4,699 9)

 

5,398 9)

 

4,737 9)

 

 

 

 

 

21,138 9)

Christophe Fond

 

4,292

 

3,505

 

5,889

 

7,048

 

8,996

 

8,127

 

2,922

 

40,779

Martin Grieder

 

3,829

 

3,085

 

5,513

 

6,598

 

8,422

 

10,594

 

12,948

 

50,989

Robert (Rob) Woolley 10)

 

3,451

 

6,279

 

 

 

 

 

 

 

 

 

 

 

9,730

Total

 

46,012

 

42,253

 

50,501

 

57,480

 

61,560

 

105,264

 

15,870

 

378,940

1) Exercise price CHF 233.40, vesting period 1.2.2023–1.6.2027 whereas one tranche being vested each year, end of restriction period 31.1.2028, exercise period 1.2.2028–31.1.2033.

2) Exercise price CHF 333.60, vesting period 1.2.2022–1.6.2026 whereas one tranche being vested each year, end of restriction period 31.1.2027, exercise period 1.2.2027–31.1.2032.

3) Exercise price CHF 218.70, vesting period 1.2.2021–1.6.2025 whereas one tranche being vested each year, end of restriction period 31.1.2026, exercise period 1.2.2026–31.1.2031.

4) Exercise price CHF 241.80, vesting period 1.2.2020–1.6.2024 whereas one tranche being vested each year, end of restriction period 31.1.2025, exercise period 1.2.2025–31.1.2030.

5) Exercise price CHF 182.40, vesting period 1.2.2019–1.6.2023 whereas one tranche being vested each year, exercise period 1.6.2020–31.1.2029.

6) Exercise price CHF 147.85, vesting period 1.2.2018–1.6.2022 whereas one tranche being vested each year, exercise period 1.6.2019–31.1.2028.

7) Exercise price CHF 130.00, vesting period 1.2.2017–1.6.2021 whereas one tranche being vested each year, exercise period 1.6.2018–31.1.2024.

8) Includes the one-time, non-recurring performance option grant (47,415 options); exercise price of CHF 147.85, vesting period of 1.2.2018 – 1.4.2025, exercise period 1.4.2025 – 30.9.2027.

9) SARs were granted instead of options (SARs grant the right to participate in the appreciation of Sonova shares without issuance of shares).

10) Member of the Management Board since April 2022.

 

31.03.2022

 

 

Options EEAP 22 1)

 

Options EEAP 21 2)

 

Options EEAP 20 3)

 

Options EEAP 19 4)

 

Options EEAP 18 5)

 

Options EEAP 17 6)

 

Options EEAP 16 7)

 

Total options

Arnd Kaldowski

 

16,871

 

25,454

 

28,119

 

32,901

 

86,543 9)

 

 

 

 

 

189,888

Birgit Conix 8)

 

4,655

 

 

 

 

 

 

 

 

 

 

 

 

 

4,655

Ludger Althoff

 

2,734

 

4,736

 

5,668

 

5,283

 

 

 

 

 

 

 

18,421

Claudio Bartesaghi

 

2,355

 

4,210

 

4,649

 

4,881

 

4,984

 

2,148 10)

 

 

 

23,227

Vicky Carr-Brendel

 

2,769 11)

 

4,699 11)

 

5,398 11)

 

4,737 11)

 

 

 

 

 

 

 

17,603 11)

Claude Diversi

 

2,381

 

5,639

 

6,748

 

4,307

 

2,649

 

 

 

 

 

21,724

Christophe Fond

 

3,505

 

5,889

 

7,048

 

8,996

 

8,127

 

6,622

 

 

 

40,187

Martin Grieder

 

3,085

 

5,513

 

6,598

 

8,422

 

10,594

 

12,948

 

 

 

47,160

Andi Vonlanthen

 

2,278

 

5,639

 

6,748

 

8,614

 

10,594

 

12,948

 

7,737

 

54,558

Total (active members)

 

40,633

 

61,779

 

70,976

 

78,141

 

123,491

 

34,666

 

7,737

 

417,423

Hartwig Grevener 12)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total (including former members)

 

40,633

 

61,779

 

70,976

 

78,141

 

123,491

 

34,666

 

7,737

 

417,423

1) Exercise price CHF 333.60, vesting period 1.2.2022–1.6.2026 whereas one tranche being vested each year, end of restriction period 31.1.2027, exercise period 1.2.2027–31.1.2032.

2) Exercise price CHF 218.70, vesting period 1.2.2021–1.6.2025 whereas one tranche being vested each year, end of restriction period 31.1.2026, exercise period 1.2.2026–31.1.2031.

3) Exercise price CHF 241.80, vesting period 1.2.2020–1.6.2024 whereas one tranche being vested each year, end of restriction period 31.1.2025, exercise period 1.2.2025–31.1.2030.

4) Exercise price CHF 182.40, vesting period 1.2.2019–1.6.2023 whereas one tranche being vested each year, exercise period 1.6.2020–31.1.2029.

5) Exercise price CHF 147.85, vesting period 1.2.2018–1.6.2022 whereas one tranche being vested each year, exercise period 1.6.2019–31.1.2028.

6) Exercise price CHF 130.00, vesting period 1.2.2017–1.6.2021 whereas one tranche being vested each year, exercise period 1.6.2018–31.1.2024.

7) Exercise price CHF 124.20, vesting period 1.2.2016–1.6.2020 whereas one tranche being vested each year, exercise period 1.6.2017–31.1.2023.

8) Member of the Management Board since June 2021.

9) Includes the one-time, non-recurring performance option grant (47,415 options); exercise price of CHF 147.85, vesting period of 1.2.2018 – 1.4.2025, exercise period 1.4.2023 – 30.9.2027.

10) SARs EEAP 2017 (SARs grant the right to participate in the appreciation of Sonova shares without issuance of shares).

11) SARs were granted instead of options (SARs grant the right to participate in the appreciation of Sonova shares without issuance of shares).

12) Member of the Management Board until June 2021.

Glossary

AC Audit Committee
AGM Annual General Shareholdersʼ Meeting
AHV Old Age and Survivorsʼ Insurance
ALV Unemployment Insurance
Articles of Association Articles of Association of Sonova Holding AG
ASP Average Sales Price
BoD Board of Directors
CEO Chief Executive Officer
CFO Chief Financial Officer
CHF Swiss Francs
EBITA Earnings Before Interest, Taxes and Amortization
EEAP Executive Equity Award Plan
EPS Earnings Per Share
ESG Environmental, Social and Governance
FCF Free Cash Flow
GVP Group Vice President
HRM Human Resource Management
KPIs Key Performance Indicators
MB Management Board
n.a. Not applicable
NCC Nomination and Compensation Committee
OPEX Operating Expenses
PSU Performance Share Unit
ROCE Return on Capital Employed
RSU Restricted Share Unit
rTSR relative Total Shareholder Return
SLI Swiss Leaders Index
SMI Swiss Market Index
Sonova Excellence Sonova Excellence System
VCC Variable Cash Compensation